Sodium alginate, sodium bicarbonate, calcium carbonate.
Peppermint flavoured and white to off-white coloured suspension.
Active Ingredients: Each 10 mL contains: Sodium Alginate 500 mg, Sodium Bicarbonate 213 mg, Calcium Carbonate 325 mg.
Preserved with Methyl Hydroxybenzoate 0.2% w/v, Propyl Hydroxybenzoate
0.02% w/v.
Pharmacology: Pharmacodynamics: GastroRelief Reflux Double Action Suspension is a combination of two antacids (calcium carbonate and sodium bicarbonate) and an alginate.
On ingestion, the suspension reacts rapidly with gastric acid to form a raft of alginic acid gel having a near neutral pH and which floats on the stomach contents effectively impeding gastro-oesophageal reflux. In severe cases, the raft itself may be refluxed into the oesophagus, in preference to the stomach contents, and exert a demulcent effect.
Calcium carbonate neutralises gastric acid to provide fast relief from indigestion and heartburn. This effect is increased by the addition of sodium bicarbonate which also has a neutralising action. The total neutralising capacity of the product at the lowest dose of 10 mL dose is approximately 10 mEqH+.
Pharmacokinetics: The mode of action of the medicinal product is physical and does not depend on absorption into the systemic circulation.
For the relief of pain and discomfort resulting from gastro-oesophageal reflux (GERD) such as acid regurgitation, heartburn and indigestion, which can occur after meals or during pregnancy, and for symptoms of excess stomach acid (hyperacidity).
For oral use only.
Adults and children above 12 years: Take 10 to 20 mL after meals and at bedtime, up to 4 times a day.
Children under 12 years: Should be given only on medical advice.
Shake well before use.
Symptoms are likely to be minor, some abdominal distension may be noticed. In the event of overdose, symptomatic treatment should be given.
Contraindicated in patients with known hypersensitivity to sodium alginate, sodium bicarbonate, calcium carbonate or to any of the excipients listed in the product.
Should not be used in patients with moderate or severe renal insufficiency.
It should be used with caution in patients with congestive cardiac failure and renal impairment.
If symptoms persist after 7 days consult the doctor.
Patient may feel bloated if taken too much. Consult the doctor or pharmacist.
This product has no or negligible influence on the ability to drive and use machines.
Use in Pregnancy: GastroRelief Reflux Double Action can be used during pregnancy.
It is recommended to limit the treatment duration as much as possible.
Use in Lactation: No effects of the active substances have been shown in breastfed newborns/infants of treated mothers.
This product can be used during breast-feeding.
Hypersensitivity reactions and respiratory effects have been reported very rarely.
Due to the presence of calcium and carbonates, a time-interval of 2 hours should be considered between intake of this product and the administration of other medicinal products, especially tetracyclines, fluoroquinolones, iron salts, thyroid hormones, chloroquine, bisphosphonates, and estramustine.
Store below 30°C. Protect from light and moisture.
Shelf Life: 18 months from the date of manufacture.
A02A - ANTACIDS ; Used in the treatment of acid-related disorders.
GastroRelief Reflux Double Action oral susp
(peppermint flavour) 120 mL x 1's; (peppermint flavour) 200 mL x 1's; (peppermint flavour) 250 mL x 1's
Sign Out
Continue with Google
Sign Up With Email
Already a member?
Sign In
